Editore: LAP LAMBERT Academic Publishing Jan 2022, 2022
ISBN 10: 6204740628 ISBN 13: 9786204740621
Lingua: Inglese
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
EUR 68,90
Convertire valutaQuantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Neuware -Biopharmaceuticals are innovative solutions that have revolutionized the treatment of important chronic diseases and malignancies. Monoclonal antibodies (mAbs) are one of important biopharmaceuticals. They are a group of antibodies produced by identical clones of B lymphocytes against a particular antigen. mAbs are identical in several properties. These characteristics of mAbs highlight their differences with the polyclonal antibodies which have heterogenous activities and recognize different epitopes on an antigen. This book will update readers on several cutting-edge aspects of mAbs Technology with valuable update information for Immunologist, microbiologist, pharmacologist, oncologist and toxicologist, who may be interested to understanding of the impact significance and recent advances in the field of mAbs Technology with a focus on the production processes of mAbs, their important diagnostic and therapeutic applications and the exploring of patent and scientific mapping of mAbs.Books on Demand GmbH, Überseering 33, 22297 Hamburg 132 pp. Englisch.
Editore: LAP LAMBERT Academic Publishing, 2022
ISBN 10: 6204740628 ISBN 13: 9786204740621
Lingua: Inglese
Da: Mispah books, Redhill, SURRE, Regno Unito
EUR 195,16
Convertire valutaQuantità: 1 disponibili
Aggiungi al carrellopaperback. Condizione: New. New. book.
Editore: LAP Lambert Academic Publishing, 2022
ISBN 10: 6204740628 ISBN 13: 9786204740621
Lingua: Inglese
Da: moluna, Greven, Germania
EUR 62,00
Convertire valutaQuantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Biopharmaceuticals are innovative solutions that have revolutionized the treatment of important chronic diseases and malignancies. Monoclonal antibodies (mAbs) are one of important biopharmaceuticals. They are a group of antibodies produced by identical clo.
Editore: LAP LAMBERT Academic Publishing Jan 2022, 2022
ISBN 10: 6204740628 ISBN 13: 9786204740621
Lingua: Inglese
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
EUR 68,90
Convertire valutaQuantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Biopharmaceuticals are innovative solutions that have revolutionized the treatment of important chronic diseases and malignancies. Monoclonal antibodies (mAbs) are one of important biopharmaceuticals. They are a group of antibodies produced by identical clones of B lymphocytes against a particular antigen. mAbs are identical in several properties. These characteristics of mAbs highlight their differences with the polyclonal antibodies which have heterogenous activities and recognize different epitopes on an antigen. This book will update readers on several cutting-edge aspects of mAbs Technology with valuable update information for Immunologist, microbiologist, pharmacologist, oncologist and toxicologist, who may be interested to understanding of the impact significance and recent advances in the field of mAbs Technology with a focus on the production processes of mAbs, their important diagnostic and therapeutic applications and the exploring of patent and scientific mapping of mAbs. 132 pp. Englisch.
Editore: LAP LAMBERT Academic Publishing, 2022
ISBN 10: 6204740628 ISBN 13: 9786204740621
Lingua: Inglese
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 69,73
Convertire valutaQuantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Biopharmaceuticals are innovative solutions that have revolutionized the treatment of important chronic diseases and malignancies. Monoclonal antibodies (mAbs) are one of important biopharmaceuticals. They are a group of antibodies produced by identical clones of B lymphocytes against a particular antigen. mAbs are identical in several properties. These characteristics of mAbs highlight their differences with the polyclonal antibodies which have heterogenous activities and recognize different epitopes on an antigen. This book will update readers on several cutting-edge aspects of mAbs Technology with valuable update information for Immunologist, microbiologist, pharmacologist, oncologist and toxicologist, who may be interested to understanding of the impact significance and recent advances in the field of mAbs Technology with a focus on the production processes of mAbs, their important diagnostic and therapeutic applications and the exploring of patent and scientific mapping of mAbs.